Pregnancy: There is a limited amount of data from the use of Flublok in pregnant women.
One animal study performed with trivalent recombinant influenza vaccine did not indicate direct or indirect harmful effects with respect to pregnancy, embryo-foetal development or early post-natal development.
An assessment of the risks and benefits should be performed by a health care professional before administering Flublok to a pregnant woman.
Breast-feeding: It is not known whether Flublok vaccine is excreted in human milk.
An assessment of the risks and benefits should be performed by a health care professional before administering Flublok to a breast-feeding woman.
Fertility: No human fertility data are available.
The animal study with trivalent recombinant influenza vaccine did not indicate harmful effects on female fertility.